PRESILIUM PRIVATE WEALTH, LLC

Position in LLY — ELI LILLY & Co

CIK 1939831 RADNOR, PA

Position in LLY

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$347,834

+$88,459 QoQ

Shares Held

290

+2.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.33%

of 13F equity value

Holder Rank

#4,051

of 4,605 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

PRESILIUM PRIVATE WEALTH, LLC holds $3,143,394 across 6 Drug Manufacturers - General names. LLY ranks #5 (11.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	4,342	$823,330
2	NVS	Novartis AG	4,603	$721,382
3	MRK	Merck & Co., Inc.	5,084	$653,294
4	GSK	GSK plc	6,852	$359,181
5	LLY	ELI LILLY & Co This page	290	$347,834
6	BMY	Bristol Myers Squibb Co	4,137	$238,373

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$347,834	290	+2.8%	Shares	Sole	2026-07-22
2026-03-31	$259,375	282	+7.2%	Shares	Sole	2026-04-17
2025-12-31	$282,640	263	-45.0%	Shares	Sole	2026-01-13
2025-09-30	$364,714	478	+9.9%	Shares	Sole	2025-10-21
2025-06-30	$339,095	435	—	Shares	Sole	2025-07-25
No filing history on record for this holder in this stock.